Cullinan Therapeutics, Inc. business relationships
Companies named in Cullinan Therapeutics, Inc.’s 10-K filed 2026-03-10, and public companies whose annual reports name Cullinan Therapeutics, Inc.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 4.6 / 10
- AI naming
- 2 / 100 Top 5% in its category
- Agent readiness
- 35 / 100
- AI adoption
- 0 / 100
Named in Cullinan Therapeutics, Inc.’s annual report 1
“Cullinan has a collaboration agreement with Adimab, LLC ("Adimab") (the "Adimab Collaboration Agreement").” SEC filing
Companies whose annual reports name Cullinan Therapeutics, Inc. 1
“...inhibitors against EGFR exon 20 mutations and EGFR atypical mutations that are currently in clinical trials, including Cullinan Therapeutics in collaboration with Taiho Pharmaceutical, ArriVent BioPharma in collaboration with Allist Pharmaceuticals, Black Diamond Therapeutics, Scorpion Therapeutics...” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.